2nd International Conference on

Virology and Immunology

Virology 2022

Theme: Emerging Viral Diseases and Their Treatment Techniques

We are delighted to welcome you to our upcoming 2nd  International Conference on Virology & Immunology which is scheduled for June 15-16, 2022 in Vancouver, Canada. The theme of the conference is "Emerging Viral diseases and their treatment techniques".
Virology 2022 is a global platform for Pathologists, virologists, industry professionals, marketing professionals and researchers, scientists, clinicians, academics, students, Liver oncologists, Surgeons, Research scholars, and other healthcare professionals. The primary goal of the conference is to promote the latest advancements, research, and developments, explore the challenges in Virology and Bacteriology related areas and share innovations and ideas on pathology for greater development and more effective treatments.

Session 1: Medical Virology and Parasitology
Medical parasitology traditionally has included the study of three major groups of animals: parasitic protozoa, parasitic helminthic (worms), and those arthropods that directly cause disease or act as vectors of various pathogens. A parasite is a pathogen that simultaneously injures and derives sustenance from its host. Some organisms called parasites are actually commensals, in that they neither benefit nor harm their host (for example, Endamoeba coli). Infections of humans caused by parasites number in the billions and range from relatively innocuous to fatal.
Medical Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress

Session 2: Molecular Biology Research and Viral Therapy
Molecular biology is most advance form of research field to detect the infection by going through the molecular composition of virus. Molecular therapy   includes various types of techniques such as DNA cloning, proliferation of DNA, bacterial transformation, transfection, etc. Most important techniques are polymerase chain reaction (PCR), Southern blotting, and Northern blotting. Viral therapy for cancer, also called oncolytic viral therapy. Oncolytic viral therapy can be use for the treatment of pancreatic cancer or pancreas cancer. 
Molecular Biology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress

Session 3: Plant Viral Infection and Prevention
Many plant pathogens, particularly fungi, can be controlled by the application of chemicals which interfere in some way with the metabolism of the invading pathogen, and so prevent or ameliorate disease. Unfortunately, these methods cannot be used so extensively to control plant viruses. Having few, if any, enzymes of their own, viruses depend either on enzymes already in host cells or on those that are induced as a result of infection. These enzymes are responsible for nucleic acid and protein synthesis, and chemical interruption of their activity disrupts similar enzymes essential for the normal functioning of cells. Prevention, or at least alleviation, of the effects of viruses, involves :
  • Control of vectors.
  • Breeding for resistance and the use of cross-protection methods. Each of these approaches to control will be considered
  • Elimination of sources of virus.
  • Elimination of the virus from infected plants.

Session 4: Veterinary Virology
Viruses are smaller and simpler in construction than unicellular microorganisms, and they contain only one type of nucleic acid—either DNA or RNA—never both. As viruses have no ribosomes, mitochondria, or other organelles, they are completely dependent on their cellular hosts for energy production and protein synthesis. They replicate only within cells of the host that they infect. Animal virology developed largely from the need to control viral diseases in humans and their domesticated animals. Viruses, like other infectious agents, enter the animal body through one of its surfaces. They then spread either locally on one of the body surfaces or through lymphatic and blood vessels to produce systemic infection.
Veterinary Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress

Session 5: Clinical and Diagnostic Virology
Diagnosis of any probable viral infection with the help of various tests such as, specific, assorted or conventional tests to identify the causative virus. Multiple methods are in use for laboratory diagnosis in probing the viral infections, including serology, viral culture, antigen detection, and nucleic acid detection. Due to various developments in the technology, we see high-end and quite impressive immunologic and molecular diagnostic tests are developed to provide more accurate results and to detect the viruses- type, number and to identify their pathogenicity as well. This field provides specific recommendations for diagnostic approach to clinically important viral infections.
Clinical Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress

Session 6: Covid-19 Infection, Prevention and Control
The most number of affected pregnant women is increasing, but scarce information is available about the clinical features Obstetrics Infections outcomes of pregnant patients with COVID-19 in pregnancy caused by severe acute respiratory syndrome coronavirus Moreover maternal, fatal, and neonatal outcomes of patients who were infected in late pregnancy appeared very good, and these outcomes were achieved with intensive, active management that might be the best practice in the absence of more robust data.
The clinical characteristics of these patients with COVID-19 during pregnancy were similar to those of non-pregnant adults with COVID-19 clinical symptoms from 33 Infections with or at risk of COVID-19 were mild and outcomes were favourable of the 3 neonates with symptomatic COVID-19, presented with early-onset SARS-CoV-2 infection.
Covid-19 Virus Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress

Session 7: Ebola, Marburg Viruses and Zika Virus
Zika virus typically leads to mild febrile cases, with most being asymptomatic, Ebola has severe symptoms. They are an animal origin in other words, a zoonoses. Ebola has high mortality rate Zika virus not. The Ebola can only be transmitted when symptoms are present.“Outbreak” is a term referring to a virus or a parasite that is transmitted very aggressively and therefore could potentially cause fatalities, as the recent Ebola and Zika epidemics did. Nevertheless, looking back through history, quite a few outbreaks have been reported, which turned out so deadly that essentially changed, molded and literally re-shaped the society as it is today
Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress

Session 8: HIV and STDs
HIV and STDs are the simultaneous infections of a host by multiple pathogen species. There are different co-infections that are associated with STD especially with HIV which leads to lethal condition and worsens the condition of the individual. Co-infection is of particular human health importance because these pathogen species can interact within the host. The net effect of the co-infection on human health is thought to be negative but these Interactions can have either positive or negative effects on other parasites..
  • Cancer
  • Mental and emotional health problems
  • Opportunistic infections
  • Cardiovascular disease

Why to Attend?

  • To transmit current issues and advances of your latest research.
  • For Thought provoking speeches by Scientists, Professors, Ph.D.'s and Young Researchers.
  • For Network development with Academic and Business Professionals

Benefits:

  • Accepted Abstracts will be published in our Supporting journals & also in our proceedings Book
  • Certificate Accredited by our Committee Member
  • Handbook & Certificate (Soft Copy)

Market Research:
The global Virology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the leading market holder driven by world class healthcare substructure with technological advancement practice. Asia-Pacific is likely attaining highest growth due to growing healthcare tourism in the nations of China and India. Hospitals and the Laboratories are the most dominating end-use segments

Key Drivers: Virology Market

  • Early in 2016, the WHO officially issued a warning about the possible spread of zika virus to each Western Hemispheric region, as the disease vector Aedes aegypti was found to thrive strong in tropical and sub-tropical climatic conditions. This has been a key driver of market growth throughout 2016.
  • The virology market is constantly catering to the prevention and cure needs put forth by the healthcare sector; however, several diseases continue to demand R&D of novel applications, driving the growth of virology market. Various treatments and diagnostic processes also employ virology applications, further fuelling the market growth.
  • Burgeoning applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology is another factor fostering the overall growth of the virology market.
  • Moreover, the field of virology is extending in various forms, including molecular virology, paediatric virology, computational virology, and many more, prompting at increasing research findings throughout the forecast period. Research prospects are high and FMI indicates a continuing need for trained virologists in the near future.
  • Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also a key factor increasing public awareness and eventually influencing the market.

Key Restraints to Market Growth:
Maintaining the quality and safety standards of viral a controlling therapy has been a longstanding challenge, which is anticipated to hamper the market in the forecast period as well. Moreover, stringent approval processes for antiviral drugs is also foreseen to be a restraint to market growth. Another factor identified for affecting the market growth includes resistance toward and side effects of antiviral drugs for new treatment options.

Current Trends in the Virology Field:

  • In 2015, the virology industry was predominantly influenced by ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with better prospects in the near future.
  • Virologists are persistently investigating novel applications for viruses. Currently, an on-going research is experimenting on the exploitation of viruses for plant production, aiming at the efficient production of high quality, eco-friendly food.

Global Virology Market: Competitive Landscape:

  • By 2017 end, a few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. Following expiry of these blockbuster drugs, the market is estimated to discover a dynamic competitive landscape. The generic competition in the virology market will be at a high pace 2017 onward.
  • Apart from expiring drugs, the market also has some late stage pipeline drugs, including Inavir, Elvitegravir, Vicriviroc, Rilpivirine, and Rapiacta. These drugs are set to enter the global market, fostering the competition globally.

Regional Outlook: Global Virology Market:

  • North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.
  • Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.
  • Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.

Segment-wise Market Forecast:

  • Immunoprophylaxis therapy and antiviral drugs are the fastest-growing market segments in the estimated forecast period.
  • STDs, urinary tract infections, and respiratory tract infections are currently dominating compared to other application types in the global virology market.
  • On the basis of diagnosis tests, hepatitis B, hepatitis C, HIV, human papillomavirus (HPV), and other tests (influenza, ebola, and dengue) are estimated to attract the largest market shares globally.
  • Hospitals and laboratories projected to continue the most dominating end-use segments, accounting for almost 50% market share globally.

Key Players in the Global Virology Market:

  • The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.
  • Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer's, ebola, and HIV. The company also has many other candidates, which are currently under review.
  • Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.
  • The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and application.

Market Research and Market Trends of Virology market

  • Notable advances in nanotechnology, nanostructure-based electrical sensors have been emerged as promising platforms for real-time, sensitive detection of numerous bioanalytes. Using Nano pore-Based Resistive-Pulse Sensing Techniques, scientists are determining both the dimensions and the number of viruses. So, this provides important complementary information and detects all viruses and virus related particles.
  • Microbiology testing considered as one of the most rapidly growing segments in the diagnostics industry. The major driving forces for this include continuous spread of HIV, which is the world's major health threat and is a key factor contributing to the rise in opportunistic infections, bioterrorism, advances in molecular diagnostic technologies, and a wider availability of immune suppressive drug.
  • Awareness programs about various viruses such as Ebola virus, Flu, Zika virus, STD’s, AIDS are the key factor increasing people awareness and eventually increasing the market growth by employing the virology applications.

International Conference on Virology and Immunology helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in science and medicine.

We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company.

If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3million hits a month on our website, we have engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains. We maintain high quality and ethical standards of publication industry, which make us unique and better than the rest.

Our attendees can be your upcoming customers. If you sell research materials, recycling products, chemicals or relevant equipment or services, here is the opportunity to advertise in the website that can connect you to leading experts and science specialists worldwide.

Meetings International is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings International has been associated with national and international associations, corporations and high level individuals, dedicated to host world class conferences and events. Meetings International supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia, and industry.

Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

For further queries, connect our conference manager at virology@annualsummits.com

You can also connect us via WhatsApp: +65 3158 1626/ +44 1392 914 058

Young Scientist Awards at Virology Conferences 2022 for the best researches in Virology:
Meetings International is announcing Young Scientist Awards through the  International Conference on Virology and Immunology (Virology 2022) which is scheduled at Vancouver, Canada during June 15-16, 2022.This Virology Conference focuses on “Emerging viral diseases and their treatment techniques”.

Virology Conferences and upcoming conferences will recognise participants who have significantly added value to the scientific community of immunology and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Eligibility:
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits:
The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:
Official announcement of the recipients will occur after the completion of Virology Conference 2022.

Meetings International recognizes the commitment and amazing work in all fields of academics and research. By recognizing their contribution; Meetings International inspires and motivates scholars, researchers and academics by awarding the Best YRF and Researcher Awards in all academic disciplines and categories along with other specific awards. These awards include prestigious Certificate of Award with other gifts.

Keynote Speaker Awards:
Virology Conferences chooses a relevant keynote speaker to speak at conference. All accepted keynote speakers proposals will be considered for the Best Keynote Speaker Awards. The committee will select a number of candidates for the award among the accepted proposals. The winner will be selected at the conference, taking into consideration both the proposal and the presentation. Best keynote speaker can help to boost motivation, change their way of thinking and make audience energized and inspired. For Keynote the person should be eminent or highly affiliated like Dean, Professor, HOD, Chair persons, CEO, CFO, MD etc.  Selection of the Best Keynote Speaker will be made on the basis of the participant contribution and years of experience in the respective research field. Each submission will be accepted based on the quality of abstract and conference theme. Irrelevant submissions will be rejected .The acceptance and rejection of abstract submissions will be selected by the Organizing committee. All submissions will go through a quality checking. Final approved abstract will consider for Keynote awards.

Outstanding Speaker Awards
Virology Conferences 2022 believes in recognising our best speaker. The best speaker is selected as per their research abstract before the conference. All winners are determined by a selection panel. This award is designed to recognise and identify outstanding speakers who have achieved recent extraordinary eminence and success. Being an outstanding speaker means to deliver a message that engages an audience. The outstanding speaker awards will also be given on the basis of organization and professionalism of presentation, communication skills of the presenter and appropriate use of time. Each session will be evaluated separately. For speaker the person should be Professor, Researcher, Scientist, and Entrepreneur etc. Selection of the Speaker will be made on the basis of the participant contribution in the respective research field. Each submission will be accepted based on the quality of abstract and conference sessions. Irrelevant submissions will be rejected. The acceptance and rejection of abstract submissions will be selected by the Organizing committee. All submissions will go through a procedure of quality checking by our team. Final approved abstract will consider for outstanding speaker award.

OCM Award
The organising committee can avail in the process of managing the multiple tasks that need to be done. Committee members, having a good erudition of the event management plan, are well placed to provide training, supervision and assistance to other personnel involved in the organisation of the event. Meetings International will honour as a best OCM the individual who has demonstrated their support and guidance throughout the conference. OCM should be eminent or highly affiliated like Dean, Professor, HOD, Chair persons, CEO, CFO, MD etc. Selection of the best OCM will be made on the basis of the participant contribution and years of experience in the respective research field. They must have good number of research papers and citations and should be more number of years of experience.

Outstanding Masters/Ph.D/Post. Doc Thesis work presentation Award
Virology Conferences 2022 gives the opportunity to young researchers in the different field of conferences. The best participants are selected as per their research abstract before the conference. If you are a young and dynamic researcher than you can join our conferences to explore new idea and research. A panel of judges will select the best YRF.  Best YRF will be recognized publicly at the end of the conference. The Best YRF Awards will be given to the most outstanding presentation presented by a participant who has registered under the student category. Undergraduates, Master students, and Ph.D. students will be considered under this category. Selection of the YRF will be made on the basis of the participant contribution in the respective research field each submission will be accepted based on the sessions of the conference. Irrelevant submissions will be rejected. The acceptance and rejection of abstract submissions will be selected by the committee. All submissions will go through a quality checking. Final approved abstract will consider for YRF award.

Best Poster Awards
To be eligible for the awards Students interested in having their posters considered for the Virology Conferences 2022, they must have submitted an abstract of their poster to the conference. The award committee will consider all posters that relate to the study of public opinion, whether they focus on theory, substantive findings, research methods, and/or statistical techniques used in such research. All posters will automatically be considered for the Poster Awards and the posters will take place in the conference venue and Poster Judges will select the best posters. The winners will be formally announced during the closing ceremony. The winners will receive a certificate award.

Guidelines for Poster

  • Poster Size: Each poster should be approximately 1x1 M long. The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.
  • Content: Use fonts such as Arial/Times New Roman in a reasonable font size that should be easy to read.
  • The spacing between the lines should also be taken into consideration.
  • A very simple format should be used representing all the details about the research carried by the author.
  • Long narrated paragraphs should be avoided.
  • Short phrases and bulleted points should be used in the poster to present the main highlights of the work done.

Guidelines for Abstract

  • Only abstracts submitted in English will be reviewed.
  • Abstracts must not exceed 500 words (excluding the title, author affiliation and biography)
  • Abstract should follow the instructions on the following template (Abstract Template).
  • Do not include references or figures in the keynote abstract.
  • Abstract should contain biography, photograph and short description about research
  • Abstract must contain presenter name, affiliation and country
  • Abstract title and abstract content should be relevant
  • Medical virology and parasitology
  • Molecular biology research and viral therapy
  • Plant Viral infection and Prevention
  • Veterinary Virology
  • Clinical and Diagnostic Virology
  • Covid-19 Infection, Prevention and Control
  • Ebola, Marburg Viruses and Zika Virus
  • HIV and STDs

2 Organizing Committee Members

OCM Member
Dr Ng Chin Teck

Senior Consultant Rheumatology ＆ Immunology Singapore General Hospital
Rheumatology Sengkang General Hospital
Singapore

OCM Member
Prof Brian Goh Kim Poh

Senior Consultant Hepato-pancreato-biliary and Transplant Surgery Singapore General Hospital
Hepato-pancreato-biliary and Transplant Surgery Singapore General Hospital
Singapore

More...

5 Renowned Speakers

Elidamar de Carvalho Lima

UNIFESP-SP
Brazil

Nicole Grandi

University of Cagliari
Italy

Mark Levitt

RedHill Biopharma
Israel

Jamal Alfaisal PhD

Saint-Louis University Hospital
France

Ms. Omazia Nasir

Cholistan University of Veterinary and Animal Sciences Bahawalpur
Pakistan

Media Partners & Collaborations

Virology 2022

Media Partner

Virology 2022

Media Partner

Virology 2022

Media Partner

Virology 2022

Media Partner

Virology 2022

Media Partner

Virology 2022

Media Partner